IL2 and COVID-19: Interestingly, recent studies have reported that severe cases of COVID-19 exhibit increased plasma levels of IL2, IL6, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα compared with mild cases, indicating inflammatory cytokine release is critical in COVID-19 progression [4,5].